Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 263
7
Diseases
81
Unique genes
0.116
Avg. similarity score
Seborrheic dermatitis
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Seborrheic dermatitis
Sebaceous gland disease
Erythematosquamous dermatosis
Uveal melanoma
nephrotic syndrome 14
netherton syndrome
Ichthyosis vulgaris
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Seborrheic dermatitis | 5 | 5 | 37 |
| Sebaceous gland disease | 4 | 4 | 14 |
| Erythematosquamous dermatosis | 3 | 3 | 22 |
| Uveal melanoma | 3 | 3 | 40 |
| nephrotic syndrome 14 | 2 | 2 | 1 |
| netherton syndrome | 2 | 2 | 1 |
| Ichthyosis vulgaris | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HERC2 | 4 / 7 | Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis, Uveal melanoma |
| IRF4 | 4 / 7 | Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis, Uveal melanoma |
| MC1R | 3 / 7 | Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis |
| RALY | 3 / 7 | Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis |
| SGPL1 | 3 / 7 | nephrotic syndrome 14, Seborrheic dermatitis, Uveal melanoma |
| SLC45A2 | 3 / 7 | Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis |
| SPINK5 | 3 / 7 | Erythematosquamous dermatosis, netherton syndrome, Seborrheic dermatitis |
| TYR | 3 / 7 | Erythematosquamous dermatosis, Sebaceous gland disease, Seborrheic dermatitis |
| CARD14 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| CLPTM1L | 2 / 7 | Sebaceous gland disease, Uveal melanoma |
| FAM8A1 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| FLG | 2 / 7 | Ichthyosis vulgaris, Sebaceous gland disease |
| FLYWCH2 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| FOXP1 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| IL23R | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| IL2RA | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| KLK6 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| KLK7 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| POLI | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| PRSS22 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| TAP2 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| TYK2 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| UNC5B | 2 / 7 | Seborrheic dermatitis, Uveal melanoma |
| ZBTB7A | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
| ZMIZ1 | 2 / 7 | Erythematosquamous dermatosis, Seborrheic dermatitis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Melanin biosynthesis | Reactome | 3 / 5 | 89.0× | 2.93e-6 | 1.22e-4 ✓ sig. |
| Thromboxane signalling through TP receptor | Reactome | 3 / 24 | 18.5× | 5.40e-4 | 8.45e-3 ✓ sig. |
| ADP signalling through P2Y purinoceptor 1 | Reactome | 3 / 25 | 17.8× | 6.11e-4 | 9.32e-3 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 5 / 108 | 6.9× | 7.98e-4 | 1.15e-2 ✓ sig. |
| GnRH secretion | KEGG | 4 / 65 | 9.1× | 9.51e-4 | 1.31e-2 ✓ sig. |
| G alpha (q) signalling events | Reactome | 6 / 172 | 5.2× | 1.06e-3 | 1.41e-2 ✓ sig. |
| Cholinergic synapse | KEGG | 5 / 115 | 6.4× | 1.06e-3 | 1.42e-2 ✓ sig. |
| Glutamatergic synapse | KEGG | 5 / 116 | 6.4× | 1.10e-3 | 1.46e-2 ✓ sig. |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | Reactome | 2 / 8 | 37.1× | 1.23e-3 | 1.58e-2 ✓ sig. |
| Thrombin signalling through proteinase activated receptors (PARs) | Reactome | 3 / 32 | 13.9× | 1.27e-3 | 1.63e-2 ✓ sig. |
| Interleukin-23 signaling | Reactome | 2 / 9 | 32.9× | 1.57e-3 | 1.91e-2 ✓ sig. |
| Acetylcholine regulates insulin secretion | Reactome | 2 / 9 | 32.9× | 1.57e-3 | 1.91e-2 ✓ sig. |
| Circadian entrainment | KEGG | 4 / 97 | 6.1× | 4.14e-3 | 3.87e-2 ✓ sig. |
| Human cytomegalovirus infection | KEGG | 6 / 226 | 3.9× | 4.17e-3 | 3.88e-2 ✓ sig. |
| Melanogenesis | KEGG | 4 / 101 | 5.9× | 4.78e-3 | 4.26e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| melanin biosynthetic process from tyrosine | GO:0006583 | 3 / 4 | 173× | 3.13e-7 | 3.16e-5 ✓ sig. |
| melanin biosynthetic process | GO:0042438 | 4 / 14 | 65.9× | 3.17e-7 | 3.19e-5 ✓ sig. |
| developmental pigmentation | GO:0048066 | 3 / 14 | 49.4× | 2.76e-5 | 1.15e-3 ✓ sig. |
| type II interferon-mediated signaling pathway | GO:0060333 | 3 / 15 | 46.1× | 3.44e-5 | 1.36e-3 ✓ sig. |
| macrophage activation | GO:0042116 | 3 / 23 | 30.1× | 1.31e-4 | 3.70e-3 ✓ sig. |
| lysosomal lumen pH elevation | GO:0035752 | 2 / 6 | 76.9× | 2.75e-4 | 6.32e-3 ✓ sig. |
| interleukin-23-mediated signaling pathway | GO:0038155 | 2 / 6 | 76.9× | 2.75e-4 | 6.32e-3 ✓ sig. |
| entrainment of circadian clock | GO:0009649 | 2 / 8 | 57.7× | 5.11e-4 | 9.70e-3 ✓ sig. |
| pigmentation | GO:0043473 | 3 / 39 | 17.7× | 6.41e-4 | 1.13e-2 ✓ sig. |
| positive regulation of B cell receptor signaling pathway | GO:0050861 | 2 / 9 | 51.3× | 6.55e-4 | 1.14e-2 ✓ sig. |
| phospholipase C-activating serotonin receptor signaling pathway | GO:0007208 | 2 / 9 | 51.3× | 6.55e-4 | 1.14e-2 ✓ sig. |
| positive regulation of interleukin-12 production | GO:0032735 | 3 / 43 | 16.1× | 8.54e-4 | 1.36e-2 ✓ sig. |
| cell population proliferation | GO:0008283 | 6 / 263 | 5.3× | 9.86e-4 | 1.49e-2 ✓ sig. |
| positive regulation of natural killer cell proliferation | GO:0032819 | 2 / 12 | 38.5× | 1.19e-3 | 1.68e-2 ✓ sig. |
| phototransduction, visible light | GO:0007603 | 2 / 13 | 35.5× | 1.40e-3 | 1.85e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Erythematosquamous dermatosis | Seborrheic dermatitis | 0.538 | 21 | 1.70e-57 | 1.06e-55 ✓ sig. |
| Erythematosquamous dermatosis | Sebaceous gland disease | 0.194 | 6 | 1.20e-14 | 1.78e-13 ✓ sig. |
| Sebaceous gland disease | Seborrheic dermatitis | 0.130 | 6 | 3.72e-13 | 4.94e-12 ✓ sig. |
| Seborrheic dermatitis | Uveal melanoma | 0.054 | 4 | 2.42e-6 | 1.40e-5 ✓ sig. |
| Sebaceous gland disease | Uveal melanoma | 0.058 | 3 | 5.80e-6 | 3.15e-5 ✓ sig. |
| Ichthyosis vulgaris | Sebaceous gland disease | 0.067 | 1 | 9.09e-4 | 1.56e-3 ✓ sig. |
| Erythematosquamous dermatosis | netherton syndrome | 0.043 | 1 | 1.43e-3 | 2.21e-3 ✓ sig. |
| nephrotic syndrome 14 | Seborrheic dermatitis | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| netherton syndrome | Seborrheic dermatitis | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| nephrotic syndrome 14 | Uveal melanoma | 0.024 | 1 | 2.60e-3 | 3.50e-3 ✓ sig. |